These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18492887)

  • 1. Notes on "Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent".
    Runge VM
    AJR Am J Roentgenol; 2008 Jun; 190(6):1433-4. PubMed ID: 18492887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
    Heuck A; Reiser M
    Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330
    [No Abstract]   [Full Text] [Related]  

  • 3. Gadolinium and kidney disease: are your patients at risk?
    Hollister D
    Nephrol Nurs J; 2008; 35(2):196-7. PubMed ID: 18472687
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerability of gadobenate dimeglumine in a patient with reported allergy to gadoterate meglumine.
    Moulin C; Said BB; Berard F
    AJR Am J Roentgenol; 2011 Dec; 197(6):W1163. PubMed ID: 22109336
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
    Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
    Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gadolinium-DTPA tolerance and clinical safety].
    Niendorf HP; Brasch RC
    Rontgenpraxis; 1997 Dec; 50(12):354-63. PubMed ID: 9492559
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrogenic systemic fibrosis: experimental studies confound prevailing theory of free gadolinium as a causative factor.
    Jakobsen J
    Acta Radiol; 2008 Jul; 49(6):616-7. PubMed ID: 18568551
    [No Abstract]   [Full Text] [Related]  

  • 8. Seizure after gadolinium administration.
    Hailemeskal B; Ilogu E; Khuc K; Curry C; Kelvas M
    Radiol Technol; 1999; 70(4):387. PubMed ID: 10101755
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal failure and gadolinium. The number of documented cases is rising.
    Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19537311
    [No Abstract]   [Full Text] [Related]  

  • 10. Is a mixture of gadolinium and iodinated contrast material safe during MR arthrography?
    Brown RR; Clarke DW; Daffner RH
    AJR Am J Roentgenol; 2000 Oct; 175(4):1087-90. PubMed ID: 11000170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis.
    Kefalas CH; Murray NG; Aguanno JJ; Dockery WD; Weinstein JS; Anderson K; Klintmalm GB
    Liver Transpl; 2004 Jan; 10(1):136-40. PubMed ID: 14755791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic gadolinium biodistribution and skin cellularity following a single injection of Omniscan in the rat.
    Haylor J; Dencausse A; Vickers M; Nutter F; Jestin G; Slater D; Idee JM; Morcos S
    Invest Radiol; 2010 Sep; 45(9):507-12. PubMed ID: 20697223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A horse-riding accident and haemolytic anaemia.
    Bittle CC
    Lancet; 2004 Nov 6-12; 364(9446):1728. PubMed ID: 15530636
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute pancreatitis induced by magnetic-resonance-imaging contrast agent.
    Terzi C; Sökmen S
    Lancet; 1999 Nov; 354(9192):1789-90. PubMed ID: 10577645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?
    Thomsen HS; Morcos SK; Dawson P
    Clin Radiol; 2006 Nov; 61(11):905-6. PubMed ID: 17018301
    [No Abstract]   [Full Text] [Related]  

  • 16. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
    Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of gadolinium-based contrast material in sickle cell disease.
    Dillman JR; Ellis JH; Cohan RH; Caoili EM; Hussain HK; Campbell AD; Strouse PJ
    J Magn Reson Imaging; 2011 Oct; 34(4):917-20. PubMed ID: 21769966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do MRI agents cause or worsen acute pancreatitis?
    Erenoğlu C; Uluutku AH; Top C; Akin ML; Celenk T
    Ulus Travma Acil Cerrahi Derg; 2007 Jan; 13(1):78-9. PubMed ID: 17310418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Picture of the month: FLAIR].
    Hjort N; Ashkanian M; Sølling C; Andersen G; Østergaard L
    Ugeskr Laeger; 2006 Sep; 168(38):3230. PubMed ID: 17026900
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracranial Gadolinium Deposition Following Gadodiamide-Enhanced Magnetic Resonance Imaging in Pediatric Patients: A Case-Control Study.
    McDonald JS; McDonald RJ; Jentoft ME; Paolini MA; Murray DL; Kallmes DF; Eckel LJ
    JAMA Pediatr; 2017 Jul; 171(7):705-707. PubMed ID: 28531274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.